Pharma BD Deal Intelligence
Zimmer Holdings acquired Biomet in a cash and equity transaction valued at approximately $13.35 billion (rising to ~$14 billion at close), creating Zimmer Biomet, a global leader in musculoskeletal healthcare.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Zimmer Holdings Inc. / Biomet Inc. (this deal) | 2014 | $13.3B | 63 |
| Zimmer Holdings Inc. / Centerpulse AG | 2003 | $3.2B | 60 |
| Zimmer Holdings Inc. / Paragon 28, Inc. | 2025 | $1.1B | — |
| Thermo Fisher Scientific Inc. / Life Technologies Corporation | 2013 | $15.1B | 84 |
| Merck KGaA / Sigma-Aldrich Corporation | 2014 | $17.0B | 80 |
| Becton, Dickinson and Company / C.R. Bard Inc. | 2017 | $24.0B | 77 |
| Johnson & Johnson / Synthes Inc. | 2011 | $19.7B | 77 |
← Browse all deals · How we score deals
More: 2014 deals · Zimmer Holdings Inc. deals · Multiple (undisclosed) deals